Studies have indicated a possible association between long-term use of GLP-1 receptor agonists (GLP-1RAs) and an increased risk of pancreatitis, although the underlying mechanism remains unclear (Gier et al., 2012a; Andreadis et al., 2018a). This evidence concerns the gene GLP1R and pancreatitis.